Physician profile
Danielle Mcveigh
NPI 1699230193
$4,418.06
in general payments reported to CMS, 2019-2025
21 companies · $747 in 2025
The $747 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,105 · 2022: $1,004 · 2023: $722 · 2024: $840 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,309.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,309.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,792.64 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $631.02 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $483.21 | 2021-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $263.24 | 2022-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $209.13 | 2021-2024 | Farxiga, Brilinta, Wainua |
| Atricure, INC. | $144.11 | 2022-2025 | Synergy Ablation System |
| Scpharmaceuticals INC. | $101.75 | 2023-2025 | |
| Boston Scientific Corporation | $94.40 | 2022-2025 | Farapulse, Watchman Access System |
| Medtronic, INC. | $91.36 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $89.52 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $77.35 | 2022-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $76.88 | 2021-2025 | |
| Abbott Laboratories | $71.59 | 2024-2025 | Cardiomems |
| Novo Nordisk INC | $62.46 | 2024 | Wegovy |
| Alnylam Pharmaceuticals INC. | $56.33 | 2025 | Amvuttra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $54.36 | 2022-2023 | |
| Abiomed | $30.27 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $25.22 | 2024 | |
| Kestra Medical Technology Services, INC. | $22.34 | 2025 | Assure Wcd |
| Astellas Pharma US INC | $22.14 | 2021 | |
| Biotronik INC. | $18.74 | 2023 | Amvia Edge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Mcveigh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.